Adsorption and Clearance of the Novel Fluorescent Tracer Agent MB-102 During Continuous Renal Replacement Therapy: In Vitro Results

MB-102 is a novel fluorescent tracer agent that is exclusively removed from the body by glomerular filtration. This agent can be detected transdermally to provide a real-time measurement of glomerular filtration rate at the point-of-care and is currently in clinical studies for such. MB-102 clearanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Soo M., Shieh, Jeng-Jong, Riley, Ivan R., Dorshow, Richard B., Mueller, Bruce A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Renal/Extracorporeal Blood Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298171/
https://www.ncbi.nlm.nih.gov/pubmed/37071749
http://dx.doi.org/10.1097/MAT.0000000000001943

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298171/
https://www.ncbi.nlm.nih.gov/pubmed/37071749
http://dx.doi.org/10.1097/MAT.0000000000001943

Ejemplares similares